The goal of BBI’s tools and platforms is to enable our members to explore new opportunities at the interface of basic science and precision medicine.
Below are some recent examples of our work.
The BBI is a collaboration among Seattle’s three top research institutions—The University of Washington, Seattle Children’s Hospital, and Fred Hutchinson Cancer Research Center.
Investigators based at partner institutions have equal access to our platforms at identical costs.
Tools & Data
BBI tools and data support BBI members and researchers worldwide.
BBI provides data and a repository for our datasets, analysis code, and protocols. We also provide tutorials to assist you in downloading, analyzing, and exploring these datasets.
BBI Platforms support our research.
Our goal is to support the work of our faculty, researchers, and investigators by fostering collaboration and innovation.
BBI Grant Program
The BBI invests in promising pilot research.
The Brotman Baty Institute (BBI) aims to create a community of investigators across the three founding institutions (UW, Fred Hutch, Seattle Children’s) to advance basic science and translational research with clear relevance to precision medicine. The BBI invests in innovative, collaborative projects that address basic science or translational research questions related to precision medicine. To learn more about the grants offered by BBI and to apply, contact firstname.lastname@example.org.
BBI embraces diversity and inclusion in all its work and, like the University of Washington, believes diversity is integral to excellence.
We value and honor diverse experiences and perspectives, strive to create welcoming and respectful learning environments, and promote access, opportunity, and justice for all.
July 28, 2022 | by BBI Communications
The Seattle Flu Study (SFS) and Greater Seattle Coronavirus Assessment Network Study (SCAN) are ending their active recruitment and research on July 31, 2022, after years of contributing to scientific discovery and improving public health in SeattleRead More
July 25, 2022 | by BBI Communications
BBI Member Dr. Holly Harris Collaborates on Paper with Researchers at Several Other Institutions Identifying New Insights on Extending Survival Pre-and Post-DiagnosisRead More
July 20, 2022 | by BBI Communications
What are three characteristics necessary to identify subtypes of cancer from cell-free DNA? The ability to solve difficult genetic computational problems, a high level of enthusiasm for translational cancer research, and a passion for improving the outcomes for cancer patients.Read More